Highlights of the 2nd international symposium on tribbles and diseases: tribbles tremble in therapeutics for immunity, metabolism, fundamental cell biology and cancer

Detalhes bibliográficos
Autor(a) principal: Cui, Bing
Data de Publicação: 2019
Outros Autores: Eyers, Patrick A., Dobens, Leonard L., Tan, Nguan Soon, Mace, Peter D., Link, Wolfgang, Kiss-Toth, Endre, Keeshan, Karen, Nakamura, Takuro, Pear, Warren S., Feseha, Yodit, Johnston, Jessica, Carracedo, Arkatiz, Scheideler, Marcel, llyas, Zabran, Bauer, Robert C., Erusalimsky, Jorge D., Grzesik, Dominika, Salamanca-Viloria, Juan, Lv, Xiaoxi, Jin, Yishi, Li, Ke, Velasco, Guillermo, Shang, Shuang, Lizcano, Jose M., Zhang, Xiaowei, Zhou, Jichao, Yu, Jiaojiao, Hua, Fang, Wang, Feng, Liu, Shanshan, Yu, Jinmei, Hu, Zhuowei
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.1/12538
Resumo: The Tribbles (TRIB) family of pseudokinase proteins has been shown to play key roles in cell cycle, metabolic diseases, chronic inflammatory disease, and cancer development. A better understanding of the mechanisms of TRIB pseudokinases could provide new insights for disease development and help promote TRIB proteins as novel therapeutic targets for drug discovery. At the 2nd International Symposium on Tribbles and Diseases held on May 7-9, 2018 in Beijing, China, a group of leading Tribbles scientists reported their findings and ongoing studies about the effects of the different TRIB proteins in the areas of immunity, metabolism, fundamental cell biology and cancer. Here, we summarize important and insightful overviews from 4 keynote lectures, 13 plenary lectures and 8 short talks that took place during this meeting. These findings may offer new insights for the understanding of the roles of TRIB pseudokinases in the development of various diseases. (C) 2019 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.
id RCAP_d266855faee08c128ebf7262880c12bd
oai_identifier_str oai:sapientia.ualg.pt:10400.1/12538
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Highlights of the 2nd international symposium on tribbles and diseases: tribbles tremble in therapeutics for immunity, metabolism, fundamental cell biology and cancerTribblesImmunologyMetabolismCell biologyKinase inhibitorTumorigenesisMetastasisTRIB1TRIB2TRIB3PseudokinaseInflammationAtomic structureProtein quality controlUbiqutinThe Tribbles (TRIB) family of pseudokinase proteins has been shown to play key roles in cell cycle, metabolic diseases, chronic inflammatory disease, and cancer development. A better understanding of the mechanisms of TRIB pseudokinases could provide new insights for disease development and help promote TRIB proteins as novel therapeutic targets for drug discovery. At the 2nd International Symposium on Tribbles and Diseases held on May 7-9, 2018 in Beijing, China, a group of leading Tribbles scientists reported their findings and ongoing studies about the effects of the different TRIB proteins in the areas of immunity, metabolism, fundamental cell biology and cancer. Here, we summarize important and insightful overviews from 4 keynote lectures, 13 plenary lectures and 8 short talks that took place during this meeting. These findings may offer new insights for the understanding of the roles of TRIB pseudokinases in the development of various diseases. (C) 2019 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.Agência financiadora / Número do subsídio National Key R&D Program of China (China) 2017YFA0205400 National Natural Science Foundation of China (China) 81530093 81773781 81874316 81503128 81400140 81400286 81703564 81603129 81472717 81673474 Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (China) 2016-12M-1-007 CAMS Central Public-interest Scientific Institution Basic Research Fund (China) 2017PT3104 CAMS Innovation Fund for Medical Sciences (China) 2016-I2M-3-008 201642M-1-008 201642M-1-007 201642M-1-011 201642M-1-010 BBSRC (UK) 1088 1097 NWCR (UK) 1088 1097 NSF (USA) IOS-1456023 NIH (USA) NIH R21 CA197317 Ministry of Education, Singapore (Singapore) MOE2014-T2-1-012 2012-T1-001-036 Health Research Council of New Zealand Rutherford Discovery Fellowship from the New Zealand government Fundacao para a Ciencia e a Tecnologia (FCT) UID/KM/04773/2013 Liga Portuguesa Contra o Cancro NUcleo Regional do Sul (LPCC/NRS, Portugal) FCT 2014 research grant (Portugal) SFRH/BPD/100434/2014 ProRegem grant (Portugal) PD/BD/114258/2016 European Marie Sklodowska Curie ITN Project TRAIN-TRIBBLES Research and Innovation Network (EU) 721532 British Heart Foundation (UK) PG/16/44/32146 Howat Foundation Ltd. (UK) Children with Cancer UK (UK) Bloodwise (UK) Friends of Paul O' Gorman (UK) grants of P-CREATE from Japan Agency for Medical Research and Development NIH (NIAID, USA) Alex' s Lemonade Stand Foundation (USA) Samuel Waxman Cancer Research Foundation (USA) French government (France) ANR-10-IBHU-005 ANR-11-LABX-0016-01 European Marie Sklodowska Curie ITN Project TRAIN-TRIBBLES Research and Innovation Network (UK) 721532 A* Star Institute (UK) University of Sheffield (UK) National Institutes of Health National Heart, Lung, and Blood Institute (USA) R01HL141745 National Institute of Health (USA) NS R01-035546 Spanish Ministry of Economy and Competitiveness (MINECO) (Spain) INNPACTO/IPT-2012-0614-010000 Fondo Europeo de desarrollo Regional (FEDER) (Spain) INNPACTO/IPT-2012-0614-010000 PerkinElmer Innovent Biologics Nantes Metropole (France) Region Pays de la Loire (France) Beijing Natural Science Foundation (China) 7162133ElsevierSapientiaCui, BingEyers, Patrick A.Dobens, Leonard L.Tan, Nguan SoonMace, Peter D.Link, WolfgangKiss-Toth, EndreKeeshan, KarenNakamura, TakuroPear, Warren S.Feseha, YoditJohnston, JessicaCarracedo, ArkatizScheideler, Marcelllyas, ZabranBauer, Robert C.Erusalimsky, Jorge D.Grzesik, DominikaSalamanca-Viloria, JuanLv, XiaoxiJin, YishiLi, KeVelasco, GuillermoShang, ShuangLizcano, Jose M.Zhang, XiaoweiZhou, JichaoYu, JiaojiaoHua, FangWang, FengLiu, ShanshanYu, JinmeiHu, Zhuowei2019-05-21T14:22:27Z20192019-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.1/12538eng2211-383510.1016/j.apsb.2018.12.007info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-24T10:24:31Zoai:sapientia.ualg.pt:10400.1/12538Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:03:52.554530Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Highlights of the 2nd international symposium on tribbles and diseases: tribbles tremble in therapeutics for immunity, metabolism, fundamental cell biology and cancer
title Highlights of the 2nd international symposium on tribbles and diseases: tribbles tremble in therapeutics for immunity, metabolism, fundamental cell biology and cancer
spellingShingle Highlights of the 2nd international symposium on tribbles and diseases: tribbles tremble in therapeutics for immunity, metabolism, fundamental cell biology and cancer
Cui, Bing
Tribbles
Immunology
Metabolism
Cell biology
Kinase inhibitor
Tumorigenesis
Metastasis
TRIB1
TRIB2
TRIB3
Pseudokinase
Inflammation
Atomic structure
Protein quality control
Ubiqutin
title_short Highlights of the 2nd international symposium on tribbles and diseases: tribbles tremble in therapeutics for immunity, metabolism, fundamental cell biology and cancer
title_full Highlights of the 2nd international symposium on tribbles and diseases: tribbles tremble in therapeutics for immunity, metabolism, fundamental cell biology and cancer
title_fullStr Highlights of the 2nd international symposium on tribbles and diseases: tribbles tremble in therapeutics for immunity, metabolism, fundamental cell biology and cancer
title_full_unstemmed Highlights of the 2nd international symposium on tribbles and diseases: tribbles tremble in therapeutics for immunity, metabolism, fundamental cell biology and cancer
title_sort Highlights of the 2nd international symposium on tribbles and diseases: tribbles tremble in therapeutics for immunity, metabolism, fundamental cell biology and cancer
author Cui, Bing
author_facet Cui, Bing
Eyers, Patrick A.
Dobens, Leonard L.
Tan, Nguan Soon
Mace, Peter D.
Link, Wolfgang
Kiss-Toth, Endre
Keeshan, Karen
Nakamura, Takuro
Pear, Warren S.
Feseha, Yodit
Johnston, Jessica
Carracedo, Arkatiz
Scheideler, Marcel
llyas, Zabran
Bauer, Robert C.
Erusalimsky, Jorge D.
Grzesik, Dominika
Salamanca-Viloria, Juan
Lv, Xiaoxi
Jin, Yishi
Li, Ke
Velasco, Guillermo
Shang, Shuang
Lizcano, Jose M.
Zhang, Xiaowei
Zhou, Jichao
Yu, Jiaojiao
Hua, Fang
Wang, Feng
Liu, Shanshan
Yu, Jinmei
Hu, Zhuowei
author_role author
author2 Eyers, Patrick A.
Dobens, Leonard L.
Tan, Nguan Soon
Mace, Peter D.
Link, Wolfgang
Kiss-Toth, Endre
Keeshan, Karen
Nakamura, Takuro
Pear, Warren S.
Feseha, Yodit
Johnston, Jessica
Carracedo, Arkatiz
Scheideler, Marcel
llyas, Zabran
Bauer, Robert C.
Erusalimsky, Jorge D.
Grzesik, Dominika
Salamanca-Viloria, Juan
Lv, Xiaoxi
Jin, Yishi
Li, Ke
Velasco, Guillermo
Shang, Shuang
Lizcano, Jose M.
Zhang, Xiaowei
Zhou, Jichao
Yu, Jiaojiao
Hua, Fang
Wang, Feng
Liu, Shanshan
Yu, Jinmei
Hu, Zhuowei
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Sapientia
dc.contributor.author.fl_str_mv Cui, Bing
Eyers, Patrick A.
Dobens, Leonard L.
Tan, Nguan Soon
Mace, Peter D.
Link, Wolfgang
Kiss-Toth, Endre
Keeshan, Karen
Nakamura, Takuro
Pear, Warren S.
Feseha, Yodit
Johnston, Jessica
Carracedo, Arkatiz
Scheideler, Marcel
llyas, Zabran
Bauer, Robert C.
Erusalimsky, Jorge D.
Grzesik, Dominika
Salamanca-Viloria, Juan
Lv, Xiaoxi
Jin, Yishi
Li, Ke
Velasco, Guillermo
Shang, Shuang
Lizcano, Jose M.
Zhang, Xiaowei
Zhou, Jichao
Yu, Jiaojiao
Hua, Fang
Wang, Feng
Liu, Shanshan
Yu, Jinmei
Hu, Zhuowei
dc.subject.por.fl_str_mv Tribbles
Immunology
Metabolism
Cell biology
Kinase inhibitor
Tumorigenesis
Metastasis
TRIB1
TRIB2
TRIB3
Pseudokinase
Inflammation
Atomic structure
Protein quality control
Ubiqutin
topic Tribbles
Immunology
Metabolism
Cell biology
Kinase inhibitor
Tumorigenesis
Metastasis
TRIB1
TRIB2
TRIB3
Pseudokinase
Inflammation
Atomic structure
Protein quality control
Ubiqutin
description The Tribbles (TRIB) family of pseudokinase proteins has been shown to play key roles in cell cycle, metabolic diseases, chronic inflammatory disease, and cancer development. A better understanding of the mechanisms of TRIB pseudokinases could provide new insights for disease development and help promote TRIB proteins as novel therapeutic targets for drug discovery. At the 2nd International Symposium on Tribbles and Diseases held on May 7-9, 2018 in Beijing, China, a group of leading Tribbles scientists reported their findings and ongoing studies about the effects of the different TRIB proteins in the areas of immunity, metabolism, fundamental cell biology and cancer. Here, we summarize important and insightful overviews from 4 keynote lectures, 13 plenary lectures and 8 short talks that took place during this meeting. These findings may offer new insights for the understanding of the roles of TRIB pseudokinases in the development of various diseases. (C) 2019 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.
publishDate 2019
dc.date.none.fl_str_mv 2019-05-21T14:22:27Z
2019
2019-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.1/12538
url http://hdl.handle.net/10400.1/12538
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2211-3835
10.1016/j.apsb.2018.12.007
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133273696239616